/DMED.CN

DMED.CN Stock - Diagnamed Holdings Corp.

Q: What is the analyst price target for DMED.CN?

Analyst price target information is not currently available for DMED.CN.

Q: What is DMED.CN's market cap?

Market capitalization information is not currently available for DMED.CN.

Healthcare|Medical - Healthcare Information Services|CNQ

$0.07+7.69%

+$0.01 (+7.69%) • Dec 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.07

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DMED.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-1.17

52W High$0.14

52W Low$0.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	$-24,714	$-16,055
Gross Margin	N/A	N/A	N/A	N/A
Operating Income	$-741,243	$-1,178,000	$-1,136,000	$-684,000
Net Income	$-501,000	$-1,278,000	$-1,132,000	$-1,948,000
Net Margin	N/A	N/A	N/A	N/A
EPS	$-0.01	$-0.02	$-0.01	$-0.03

Company Overview

Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.

Visit Website

Earnings History & Surprises

DMED.CN

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$0.00

Q4 2023

EPS Surprise History

Q4 21

No data

Q1 22

No data

Q4 22

No data

Q1 23

No data

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Dec 31, 2023	—	$0.00	—	—
Q1 2023	Mar 31, 2023	—	$-0.01	—	—
Q4 2022	Dec 31, 2022	—	$-0.00	—	—
Q1 2022	Mar 31, 2022	—	$-0.00	—	—
Q4 2021	Dec 31, 2021	—	$-0.00	—	—

Frequently Asked Questions about DMED.CN

What is DMED.CN's current stock price?

Diagnamed Holdings Corp. (DMED.CN) is currently trading at $0.07 per share. The stock has moved +7.69% today.

What is the analyst price target for DMED.CN?

No analyst price targets are currently available for this stock.

What sector is Diagnamed Holdings Corp. in?

Diagnamed Holdings Corp. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the CNQ exchange.

What is DMED.CN's market cap?

Diagnamed Holdings Corp. has a market capitalization of $0.01 billion, making it a small-cap company.

Does DMED.CN pay dividends?

No, Diagnamed Holdings Corp. does not currently pay a dividend to shareholders.